JP2017502956A5 - - Google Patents

Download PDF

Info

Publication number
JP2017502956A5
JP2017502956A5 JP2016542948A JP2016542948A JP2017502956A5 JP 2017502956 A5 JP2017502956 A5 JP 2017502956A5 JP 2016542948 A JP2016542948 A JP 2016542948A JP 2016542948 A JP2016542948 A JP 2016542948A JP 2017502956 A5 JP2017502956 A5 JP 2017502956A5
Authority
JP
Japan
Prior art keywords
hexafluorophosphate
acid
hydrogen
compound
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016542948A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017502956A (ja
JP6626446B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/072264 external-priority patent/WO2015100376A1/en
Publication of JP2017502956A publication Critical patent/JP2017502956A/ja
Publication of JP2017502956A5 publication Critical patent/JP2017502956A5/ja
Application granted granted Critical
Publication of JP6626446B2 publication Critical patent/JP6626446B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016542948A 2013-12-27 2014-12-23 薬学的に適切な芳香族カチオン性ペプチド Active JP6626446B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361921376P 2013-12-27 2013-12-27
US61/921,376 2013-12-27
US201461947261P 2014-03-03 2014-03-03
US61/947,261 2014-03-03
PCT/US2014/072264 WO2015100376A1 (en) 2013-12-27 2014-12-23 Pharmaceutically relevant aromatic-cationic peptides

Publications (3)

Publication Number Publication Date
JP2017502956A JP2017502956A (ja) 2017-01-26
JP2017502956A5 true JP2017502956A5 (https=) 2018-02-08
JP6626446B2 JP6626446B2 (ja) 2019-12-25

Family

ID=53479676

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016542948A Active JP6626446B2 (ja) 2013-12-27 2014-12-23 薬学的に適切な芳香族カチオン性ペプチド

Country Status (6)

Country Link
US (2) US10221213B2 (https=)
EP (1) EP3087093B1 (https=)
JP (1) JP6626446B2 (https=)
CN (2) CN112457368A (https=)
CA (1) CA2935207C (https=)
WO (1) WO2015100376A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6626446B2 (ja) * 2013-12-27 2019-12-25 ステルス バイオセラピューティックス コープ 薬学的に適切な芳香族カチオン性ペプチド
EP3160984B1 (en) * 2014-06-25 2021-04-14 Flamma S.P.A. Process for preparing d-arginyl-2,6-dimethyl-l-tyrosyl-l-lysyl-l-phenylalaninamide
WO2016001042A1 (en) * 2014-06-30 2016-01-07 Flamma S.P.A. Process for the production of d-arginyl-2,6-dimethyl-l-tyrosyl-l-lysyl-l-phenylalaninamide
US10633415B2 (en) 2015-03-06 2020-04-28 Stealth Biotherapeutics Corp Processes for preparing pharmaceutically relevant peptides
CA3020393A1 (en) 2016-04-11 2017-10-19 Carnot, Llc Chiral peptides
CN110087667A (zh) * 2016-08-16 2019-08-02 隐形生物治疗公司 Elamipretide的基于N-羧基酸酐的规模合成
CN110914287A (zh) 2017-04-05 2020-03-24 隐形生物治疗公司 Boc-d-arg-dmt-lys-(boc)-phe-nh2的结晶盐形式
US20200361987A1 (en) * 2017-11-15 2020-11-19 Stealth Biotherapeutics Corp. Deuterated tetrapeptides that target mitochondria
US10676506B2 (en) 2018-01-26 2020-06-09 Stealth Biotherapeutics Corp. Crystalline bis- and tris-hydrochloride salt of elamipretide
CN108929371A (zh) * 2018-08-02 2018-12-04 哈尔滨师范大学 一种Phakellistatin13直链衍生物、其制备办法及用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2067000C1 (ru) * 1994-06-29 1996-09-27 Владислав Исакович Дейгин Пептид и способ его получения
US6248716B1 (en) * 1995-06-27 2001-06-19 Immunotech Developments Inc. Peptide, a method for its preparation and a pharmaceutical composition containing the peptide
US20030069231A1 (en) * 1999-10-12 2003-04-10 Klaus Rudolf Modified aminoacids, pharmaceuticals containing these compounds and method for their production
US7214663B2 (en) 2000-06-14 2007-05-08 Medarex, Inc. Tripeptide prodrug compounds
US9278085B2 (en) 2006-02-22 2016-03-08 Edison Pharmaceuticals, Inc. Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
US20070213505A1 (en) * 2006-03-08 2007-09-13 David Epstein Solution Synthesis of Peptide Cell Growth Stimulators
EP3375449A1 (en) 2010-03-15 2018-09-19 Stealth Peptides International, Inc. Combination therapies using cyclosporine and aromatic cationic peptides
AU2012271691A1 (en) * 2011-06-14 2014-01-16 Stealth Peptides International, Inc. Aromatic-cationic peptides and uses of same
HK1204988A1 (en) * 2012-02-22 2015-12-11 Stealth Peptides International, Inc. Methods and compositions for preventing or treating ophthalmic conditions
EP2928562A4 (en) * 2012-12-06 2016-06-22 Stealth Peptides Int Inc PEPTIDE THERAPEUTIC PRODUCTS AND METHODS OF USE
EP3060573B1 (en) 2013-10-23 2019-07-17 Kaneka Corporation Tetrapeptide compound and method for producing same
JP6626446B2 (ja) * 2013-12-27 2019-12-25 ステルス バイオセラピューティックス コープ 薬学的に適切な芳香族カチオン性ペプチド
HK1231493A1 (zh) * 2014-03-03 2017-12-22 Stealth Biotherapeutics Corp 药学上相关的芳香族阳离子肽

Similar Documents

Publication Publication Date Title
JP2017502956A5 (https=)
JP2017512762A5 (https=)
ES2552338T3 (es) Compuestos farmacéuticos
KR101742253B1 (ko) 비페닐-2-일카르밤산의 제조방법
ES2553874T3 (es) N-Carboxialquil-auristatinas y su uso
JP7450572B2 (ja) 薬学的に適切なペプチドを調製するための方法
ES2730474T3 (es) Proceso para la preparación de ivacaftor y solvatos de este
CA3090936A1 (en) Processes for the preparation of an apoptosis-inducing agent
JP2017512762A (ja) 薬学的に妥当な芳香族カチオン性ペプチド及びその生成方法
JP2016539931A (ja) テトラペプチド化合物及びその製造方法
WO2020096042A1 (ja) ジメトキシベンゼン化合物の製造方法
ES2662863T3 (es) Método para preparar 1-(4-(4-(3,4-dicloro-2-fluorofenilamino)-7-metoxiquinazolin-6-iloxi)piperidin-1-il)prop-2-en-1-ona
RU2717830C2 (ru) Способ получения азотсодержащего гетероциклического соединения и его промежуточного соединения
ES2791187T3 (es) Síntesis de dabigatrán
KR102742083B1 (ko) 디메톡시벤젠 화합물의 제조 방법
KR20150067175A (ko) 보르테조밉을 제조하기 위한 방법
RU2009143867A (ru) Способы получения производных n-изобутил-n-(2-гидрокси-3-амино-4-фенилбутил)-пара-нитробензолсульфониламида
EP3228619B1 (en) Process for the preparation of apixaban
EP4646423A1 (en) Peptide synthesis method involving sterically hindered tri-tert-butyl-tryptophan (tbt) residue
US10329325B2 (en) Process for the preparation of (S)-4-methyl-N-((S)-1-(((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxo-pentan-2-yl) amino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido) pentanamide
EP2773624A1 (en) Novel process for the preparation of acylguanidines and acylthioureas
TW202328164A (zh) 加尼瑞克(ganirelix)或其鹽之製造法
Chakraborty et al. Synthesis of triazole cages containing C3-symmetric α-cyclic tripeptide scaffold
WO2019200114A1 (en) Methods for preparing substituted dihydroindene-4-carboxamide compounds
JP6440250B2 (ja) チオアミド誘導体